Zunitra 4mg Injection 1'S

Bone Metabolism Rx required
OUT OF STOCK

Best Price* ₹ 2,293.20 MRP ₹ 2,548.00
(Inclusive of all taxes) * Mkt: Samarth Life Sciences Pvt Ltd * Country of Origin: India * Delivery charges if applicable will be applied at checkout



INTRODUCTION

ZUNITRA contains Zoledronic Acid which belongs to the group of medicines called Bisphosphonates. ZUNITRA is used in post-menopausal women and adult men to treat osteoporosis or osteoporosis caused by treatment with corticosteroids and Paget’s disease of the bone in adults.

Osteoporosis is a bone disease that develops when bone mineral density and bone mass decreases or when the quality or structure of the bone changes. It usually occurs in women after the menopause and also occurs in adult men. Paget's disease of bone is a chronic bone disorder which disrupts the normal cycle of bone renewal, causing bones to become weakened and possibly deformed.

Along treatment with ZUNITRA your doctor might ask you to make some lifestyle changes such as eating balanced diet rich in calcium and vitamin D. Prior to starting the treatment with ZUNITRA your doctor might want you to take some diagnostic tests to understand the existing condition.

ZUNITRA is not recommended for use in patients with severe kidney problems and hypocalcemia (low levels of calcium in the blood). ZUNITRA is not recommended for use in pregnant and breastfeeding women. Consult your doctor before receiving ZUNITRA.

ZUNITRA is not recommended for use in children and adolescents (under 18 years of age) and should be used with caution in elderly patients. The most common side effects of receiving ZUNITRA are headache, dizziness, vomiting, diarrhoea, fever, chills, pain in muscles, joints or bones and pain in back, arms or legs. Inform your doctor if any of the symptom worsens.

USES OF ZUNITRA

  • treats osteoporosis or corticosteroid-induced osteoporosis (in post-menopausal women and adult men)
  • treats Paget’s disease of the bone (in adults)

HOW ZUNITRA WORKS

ZUNITRA works by suppressing the activity of osteoclasts, cells that cause destruction of bone. This strengthens the bones and minimizes the risk of fractures.

DIRECTIONS FOR USE

ZUNITRA will be given to you only by a doctor or a nurse into a vein (intravenously). Your doctor will decide the correct dose and duration of ZUNITRA for you depending upon your age, body weight and disease condition.

SIDE EFFECTS OF ZUNITRA

COMMON

  • fever, chills
  • pain in muscles, joints or bones
  • headache, dizziness
  • sickness, vomiting
  • diarrhoea
  • pain in back, arms or legs
  • flu-like symptoms such as tiredness, fever, muscle pain
  • lack of interest, weakness, feeling unwell
  • pain
  • swelling or pain at the infusion site
  • low calcium levels in blood (signs include muscle spasms or numbness or tingling sensation)

UNCOMMON

  • upper respiratory tract infections
  • decreased red cell count (anaemia)
  • loss of appetite, heartburn
  • sleeplessness
  • sleepiness associated with reduced alertness and awareness
  • tingling sensation or numbness, flushing
  • temporary loss of consciousness, trembling
  • eye infection or irritation or inflammation with pain and redness
  • spinning sensation (vertigo)
  • increased blood pressure
  • shortness of breath, cough
  • abdominal pain, upset stomach, constipation
  • dry mouth, thirst
  • skin rash, itching, skin reddening
  • excessive sweating
  • stiffness in muscles, bones or joints
  • shoulder or neck pain, muscle spasms
  • pain in chest muscles and rib cage
  • joint inflammation
  • muscular weakness
  • abnormal frequent urination
  • extreme tiredness, swelling of hands, ankles or feet
  • toothache
  • taste disturbances

RARE

  • low levels of phosphate in blood
  • unusual fracture of thigh bone (symptoms such as pain, weakness or discomfort in thigh, hip or groin)

Consult your doctor if you experience any of the following side effects after receiving ZUNITRA:

  • irregular heart rhythm (atrial fibrillation)
  • swelling, redness, pain and itching to the eyes or eye sensitivity to light
  • osteonecrosis of the jaw (signs include any problems with your mouth or teeth such as loose teeth, pain or swelling, or non-healing of sores or discharge)

HOW TO MANAGE SIDE EFFECTS

Headache:

Drink ample amount of water and avoid skipping meals. Get adequate rest. Try to be relaxed and stress free. Apply pain relieving balm on your forehead if necessary. Inform your doctor if the symptom does not improve.

Vomiting:

Stick to simple meals. Avoid eating oily, fried or spicy foods. Do not lie down or sleep immediately after eating. Inform your doctor if the symptom does not improve.

Dizziness:

Lie down until dizziness is gone, then get up slowly. Move slowly and carefully, do not hurry. Get adequate rest. Drink plenty of water and other fluids. Inform your doctor if the symptom gets worse.

Diarrhoea:

Drink lot of fluids such as water to keep yourself hydrated. Avoid eating high fat or spicy foods. Inform your doctor if the symptom gets worse.

Constipation:

Try to eat more high-fiber foods such as fresh fruit, vegetables, cereals, and drink plenty of water. If this does not help, inform your doctor for receiving alternate treatment for constipation.

Abdominal pain:

Try to rest and relax. Eat and drink slowly or try to have smaller and frequent meals. Keep a heat pad on your stomach. If the symptom does not improve, inform your doctor.

WARNING & PRECAUTIONS

PREGNANCY

ZUNITRA is not recommended for use in pregnant women. Consult your doctor before receiving ZUNITRA.

BREASTFEEDING

ZUNITRA is not recommended for use in breastfeeding women. Consult your doctor before receiving ZUNITRA.

DRIVING AND USING MACHINES

Do not drive or operate any machines if you feel dizziness after receiving ZUNITRA.

KIDNEY

ZUNITRA is not recommended for use in patients with severe kidney disease and it should be used with caution in patients with other kidney problems. Consult your doctor before receiving ZUNITRA.

ALLERGY

Do not receive ZUNITRA if you are allergic to Zoledronic Acid or other bisphosphonate (such as alendronate) or any of the other ingredients of this medicine.

OTHERS

ZUNITRA is not recommended for use if you:

  • have hypocalcaemia (low levels of calcium in the blood)

Before receiving ZUNITRA inform your doctor if you:

  • are unable to take daily calcium supplements
  • have had some or all of the parathyroid glands in neck surgically removed
  • have had intestinal sections removed
  • have any problems with mouth or teeth such as poor dental health or gum disease
  • have not received routine dental care or have not had dental check-up for long time
  • are smoker (increase the risk of dental problems)
  • are under dental treatment or due to undergo dental surgery (Ex. tooth extractions)
  • have cancer

Use in paediatrics:

ZUNITRA is not recommended for use in children and adolescents (under 18 years of age). Consult child’s doctor for advice.

 Use in geriatrics:

ZUNITRA should be used with caution in elderly patients (aged 65 years and above). Consult your doctor before receiving ZUNITRA.

INTERACTIONS

A. Drug – Drug Interactions:

Before receiving ZUNITRA, inform your doctor if you are taking any of the following medicines:

  • aminoglycosides such as gentamicin (used to treat severe bacterial infections)
  • diuretics (water pills) such as chlorthalidone, indapamide (used to treat high blood pressure or oedema)
  • other bisphosphonates such as alendronate (used to treat or prevent bone disorders)
  • corticosteroids such as prednisolone or dexamethasone (used to treat inflammation)

Overdosage:

ZUNITRA will be administered to you only by a doctor or a nurse in a hospital, and so it is unlikely to receive an overdose. However, consult your doctor or nurse if you experience any unusual symptoms after receiving ZUNITRA.

SYNOPSIS

Drug :  

Zoledronic Acid

Pharmacological Category :  

Bisphosphonates

Therapeutic Indication :   Osteoporosis, Paget’s disease of the bone
Dosage Forms :  

Injection, Infusion

MORE INFORMATION

  • Store at room temperature (or) in refigerator at (2 - 8°C). Do not freeze (store the product based on the product labelling)

FAQs ABOUT ZUNITRA

How long should I receive ZUNITRA?

ZUNITRA should be received in the dose and duration as advised by your doctor. The medicine takes around 6 months to show its maximum benefits on bones. However, in some cases, the doctor may suggest ZUNITRA for a longer duration. The exact duration will depend on the condition you are being treated for.

How is ZUNITRA administered?

ZUNITRA will be given to you only by a doctor or a nurse into a vein (intravenously). Your doctor will decide the correct dose and duration of ZUNITRA for you depending upon your age, body weight and disease condition.

What are the lifestyle changes should I follow while receiving ZUNITRA?

To get maximum benefit from this medicine, there are certain lifestyle changes that you must adhere to. Include some calcium or vitamin D rich foods for bone strength. Try to spend more time in sunlight to get natural vitamin D. Quit smoking and reduce alcohol consumption as they may harm your bones. You can take up an exercise regime such as walking and low-impact aerobics as they are good for your bones. Similarly, you can try strength-training exercises where you use your own body weight which in turn improve bone health.

Can ZUNITRA cause constipation?

Yes, ZUNITRA may cause constipation in some individuals. To manage this effect, try to eat more high-fibre foods such as fresh fruit, vegetables, cereals and drink plenty of water. If this does not help, inform your doctor for receiving alternate treatment for constipation.

Is ZUNITRA safe to use in pregnant or breast-feeding women?

ZUNITRA is not recommended for use in pregnant and breast-feeding women. Consult your doctor before receiving ZUNITRA if you are pregnant or planning to pregnant or breast-feeding.

REFERENCES

1. Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. Page - 4229-4231.

2. Ma Chao, Qin Hua, Zhou Yingfeng, Wan Guang, Shi Shufeng, Dong Yuzhen, Wang Wei, and Tan Haifeng. Study on the role of zoledronic acid in treatment of postmenopausal osteoporosis women. NIH: National Library of Medicine, National center of biotechnology Information, PMC Pubmed Central. December 2013 [Accessed on 7th June 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905367/

3. Margaret Seton and Stephen M Krane. Use of zoledronic acid in the treatment of Paget’s disease. NIH: National Library of Medicine, National center of biotechnology Information, PMC, Pubmed Central. October 2007 [Accessed on 7th June 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376069/

4. Sun Pharmaceutical Industries Europe B.V. Electronic Medicines Compendium (EMC). [Revised in October 2020] [Accessed on 7th June 2022] https://www.medicines.org.uk/emc/files/pil.5242.pdf

USEFUL DIAGNOSTIC TESTS

  • Calcium Test
  • Intact Parathyroid Hormone

PRODUCT DETAILS

    Net Qty
    1 N
    Item Weight
    20 g
    Ingredient
    Zoledronic Acid 4 mg
    Hsn Code
    30049049
ALTERNATE BRANDS View All
ZORRENT 4mg Injection 1's
Prescription Bone Metabolism Rx required
Rs.2,500.00
Zoldonat 4mg Injection 1's
Prescription Bone Metabolism Rx required
Rs.2,990.00
Zobone 4mg Injection 1's
Prescription Bone Metabolism Rx required
Rs.3,398.66
DISCLAIMER

The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.

Copyright© 2023. All Rights Reserved.